M.B.A., CEO, Vineti
Biography
Ann brings more than 25 years of healthcare technology product strategy, management, sales and marketing experience to Vineti. Ann served as Chief Product Officer for Tact.ai, a leading CRM company focused on the life sciences industry. She also served as Chief Product Officer and Partner for ZS Associates and as Vice President and General Manager, Healthcare, for Vlocity (now Salesforce Industries). Earlier in her career, Ann held positions of increasing responsibility in the healthcare technology industry, including as Senior Vice President of Product Management for Risk Management Solutions, General Manager of Insurance and Healthcare at Siebel Systems (acquired by Oracle), and Senior Manager of healthcare strategy at Accenture. She also currently serves as an advisory board member for Capsico Health.
Session Abstract – PMWC 2022 Silicon Valley
Track Chair:
Ira Mellman, Genentech
Human cells have been successfully used as treatment for blood cancers for decades but translating the promise to cell-based treatment for solid tumors has been slow. The advent of gene-editing techniques such as CRISPR, coupled with advances in our understanding of immunology and optimization of growing, manufacturing, transporting, storing, and handling specialized biological samples and materials is transforming the cell therapy field. We will hear in this session about some of the most promising work in the field, as well as the challenges in overcoming resistance
-
Sessions:
- Recent Advances in Cell-based Therapy (PANEL)
Session Chair: Sascha Rutz, Genentech
- Susie Jun, ArsenalBio
- Elliot Norry, Adaptimmune
- Tina Albertson, Lyell
- Hy Levitsky, Century Therapeutics - Cell-based Therapy Challenges (PANEL)
Session Chair: Sharon Benzeno, Adaptive Biotechnologies
- Arati Rao, PACT Pharma
- Mark Kotter, bit.bio
- Hy Levitsky, Century Therapeutics - Synergistic Drug Combinations Targeting Tumor and Microenvironment
- Next-generation Supply Chain For Cell & Gene Therapies (PANEL)
Session Chair: Sharon Benzeno, Adaptive Biotechnologies
- Ann Klein, Vineti
- Tim Moore, Pact Pharma
- Heidi Hunter, Cardinal Health - Biomarkers to Guide Immunotherapy
Session Chair: Danny Wells, ImmunAI
- Sanjeev Mariathasan, Genentech
- Klaus Lindpaintner, InterVenn Bioscience
- Lacey Padron, PICI - NaNots: A New Class of Immunotherapy
- Lou Hawthorne, Nanotics - Advances in Multi-Omic Spatial Profiling
Session Chair: Michael Rhodes, Nanostring
- Chris Corless, OHSU
- Engineered Therapeutics (PANEL)
Session Chair: Paul Parren, Lava Therapeutics
- Sonja Schrepfer, UCSF
- Greg Lazar, Genentech
